Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 83,205 | 62,959 | 59,571 | 58,305 | 57,063 |
| Cost of Goods | 2,958 | 2,950 | 2,823 | 3,839 | 3,562 |
| Gross Profit | 80,247 | 60,009 | 56,748 | 54,466 | 53,501 |
| Operating Expenses | 138,296 | 148,593 | 124,846 | 116,576 | 118,142 |
| Operating Income | -57,091 | -87,634 | -67,275 | -61,271 | -64,079 |
| Other Income | 2,515 | 2,705 | 1,797 | -491 | 1,032 |
| Pre-tax Income | -54,576 | -84,929 | -65,478 | -61,762 | -63,047 |
| Income Tax | 365 | 375 | 14 | 376 | 219 |
| Net Income Continuous | -54,941 | -85,304 | -65,492 | -62,138 | -63,266 |
| Net Income | $-54,941 | $-85,304 | $-65,492 | $-62,138 | $-63,266 |
| EPS Basic Total Ops | -0.38 | -0.59 | -0.49 | -0.50 | -0.51 |
| EPS Basic Continuous Ops | -0.38 | -0.59 | -0.50 | -0.50 | -0.51 |
| EPS Diluted Total Ops | -0.38 | -0.59 | -0.49 | -0.50 | -0.51 |
| EPS Diluted Continuous Ops | -0.38 | -0.59 | -0.50 | -0.50 | -0.51 |
| EBITDA(a) | $-57,385 | $-87,855 | $-66,656 | $-60,694 | $-63,434 |